Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America, 1st Edition

Name: Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America
SKU: 9780323896924
Price: 98.09 USD

Author :

Edited by Jennifer R. Brown?, MD, PhD

This issue of Hematology/Oncology Clinics, guest edited by Dr. Jennifer R. Brown?, will focus on Chronic Lymphocytic Leukemia. This issue is one of six selected each year by our series consulting editors, Dr. George P. Canellos and Dr. Edward J. Benz. Topics discussed in this issue will include: Chronic Lymphocytic Leukemia: Do We Know the Cell of Origin Yet?; Significance of BCR Stereotypy; Prognostic and Predictive Implications of Cytogenetics and Genomics; Role of Epigenetics in Chronic Lymphocytic Leukemia; Genomics of Resistance to Targeted Therapies; First Line Therapy for Chronic Lymphocytic Leukemia; The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia Therapy; BTK Inhibitors; Minimal Residual Disease; Should Undetectable MRD Be the Goal of Chronic Lymphocytic Leukemia Therapy?; Management of Chronic Lymphocytic Leukemia after Progression on BTK Inhibitors; Role of PI3K Inhibitors in Chronic Lymphocytic Leukemia; Can We Restore the Immunodeficiency of Chronic Lymphocytic Leukemia?; and Immune Therapy for Chronic Lymphocytic Leukemia

ISBN :

9780323896924

Publication Date :

15-07-2021

Be the first to review this product

printebook Book

Special Price $98.09 $108.99

printebook VitalSource eBook

VitalSource Bookshelf gives you access to content when, where, and how you want. When you read an eBook on VitalSource Bookshelf, enjoy such features as:

Access online or offline, on mobile or desktop devices.
Bookmarks, highlights and notes sync across all your devices.
Smart study tools such as note sharing and subscription, review mode, and Microsoft OneNote integration.
Search and navigate content across your entire Bookshelf library.
Interactive notebook and read-aloud functionality.
Look up additional information online by highlighting a word or phrase.

Special Price $83.69 $92.99

Qty

printebook Book

Special Price $98.09 $108.99

Add to Cart

printebook VitalSource eBook

Special Price $83.69 $92.99

Add to Cart

10% OFF

Description

Author Information

Edited by Jennifer R. Brown?, MD, PhD, Professor of Medicine, Harvard Medical School,Director of CLL Center, Dana-Farber Cancer Institute

Product Details

More Information
ISBN Number	9780323896924
Description Author List	Edited by Jennifer R. Brown?, MD, PhD, Professor of Medicine, Harvard Medical School,Director of CLL Center, Dana-Farber Cancer Institute
Copyright Year	2021
Edition Number	1
Format	Book
Trim	152w x 229h (6.00" x 9.00")
Imprint	Elsevier
Page Count	240
Publication Date	15 Jul 2021
Stock Status	IN STOCK

Table Of Contents

Potential Relevance of B-cell Maturation Pathways in Defining the Cell(s) of Origin for Chronic Lymphocytic LeukemiaThe Significance of B-cell Receptor Stereotypy in Chronic Lymphocytic Leukemia: Biological and Clinical ImplicationsPrognostic and Predictive Implications of Cytogenetics and GenomicsGenomics of Resistance to Targeted TherapiesFirst-Line Therapy for Chronic Lymphocytic Leukemia: Bruton Tyrosine Kinase or BCL2 or Both?The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia: TP53 Disruption, Richter, and BeyondBruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: Beyond IbrutinibShould Undetectable Minimal Residual Disease Be the Goal of Chronic Lymphocytic Leukemia Therapy?Treatment of Chronic Lymphocytic Leukemia After Discontinuation of Bruton’s Tyrosine Kinase InhibitorsThe Evolving Use of Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Chronic Lymphocytic LeukemiaCan Immunocompetence Be Restored in Chronic Lymphocytic Leukemia?Immune Therapy for Chronic Lymphocytic Leukemia: Allogeneic Transplant, Chimeric Antigen Receptor T-cell Therapy, and Beyond

Reviews

Write Your Own Review

Only registered users can write reviews. Please sign in or create an account

https://www.asia.elsevierhealth.com/chronic-lymphocytic-leukemia-an-issue-of-hematologyoncology-clinics-of-north-america-9780323896924.html 297959 Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America https://www.asia.elsevierhealth.com/media/catalog/product/9/7/9780323896924_4.jpg 98.09 108.99 USD InStock /Clinics /Medicine & Surgery/Hematology /Medicine/Hematology /Clinics /Clinics /Medicine/Hematology /Japan Titles 4388725 4431214 5054622 5054666 5255041 5259911 5263160 1 4182692 4335088 4886536 5054553 5145120 5259833 This issue of Hematology/Oncology Clinics, guest edited by Dr. Jennifer R. Brown?, will focus on Chronic Lymphocytic Leukemia. This issue is one of six selected each year by our series consulting editors, Dr. George P. Canellos and Dr. Edward J. Benz. Topics discussed in this issue will include: Chronic Lymphocytic Leukemia: Do We Know the Cell of Origin Yet?; Significance of BCR Stereotypy; Prognostic and Predictive Implications of Cytogenetics and Genomics; Role of Epigenetics in Chronic Lymphocytic Leukemia; Genomics of Resistance to Targeted Therapies; First Line Therapy for Chronic Lymphocytic Leukemia; The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia Therapy; BTK Inhibitors; Minimal Residual Disease; Should Undetectable MRD Be the Goal of Chronic Lymphocytic Leukemia Therapy?; Management of Chronic Lymphocytic Leukemia after Progression on BTK Inhibitors; Role of PI3K Inhibitors in Chronic Lymphocytic Leukemia; Can We Restore the Immunodeficiency of Chronic Lymphocytic Leukemia?; and Immune Therapy for Chronic Lymphocytic Leukemia This issue of Hematology/Oncology Clinics, guest edited by Dr. Jennifer R. Brown?, will focus on Chronic Lymphocytic Leukemia. This issue is one of six selected each year by our series consulting editors, Dr. George P. Canellos and Dr. Edward J. Benz. Topics discussed in this issue will include: Chronic Lymphocytic Leukemia: Do We Know the Cell of Origin Yet?; Significance of BCR Stereotypy; Prognostic and Predictive Implications of Cytogenetics and Genomics; Role of Epigenetics in Chronic Lymphocytic Leukemia; Genomics of Resistance to Targeted Therapies; First Line Therapy for Chronic Lymphocytic Leukemia; The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia Therapy; BTK Inhibitors; Minimal Residual Disease; Should Undetectable MRD Be the Goal of Chronic Lymphocytic Leukemia Therapy?; Management of Chronic Lymphocytic Leukemia after Progression on BTK Inhibitors; Role of PI3K Inhibitors in Chronic Lymphocytic Leukemia; Can We Restore the Immunodeficiency of Chronic Lymphocytic Leukemia?; and Immune Therapy for Chronic Lymphocytic Leukemia 0 0 add-to-cart 9780323896924 2021 Professional Edited by Jennifer R. Brown?, MD, PhD 2021 1 Book 152w x 229h (6.00" x 9.00") Elsevier 240 Jul 15, 2021 IN STOCK Edited by Jennifer R. Brown?, MD, PhD, Professor of Medicine, Harvard Medical School,Director of CLL Center, Dana-Farber Cancer Institute Clinics Clinics The Clinics: Internal Medicine United States No No No No Please Select Please Select Please Select